Sec. 207. Global public health risk reduction program
199 words·~1 min read·
/bill/116/s/4629/is/section-207A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
It is the sense of Congress that— recurring outbreaks of emerging and reemerging zoonotic diseases, including Ebola virus disease, severe acute respiratory syndrome, and avian influenza, pose an increasing threat to lives and livelihood, demonstrating the need to engage in a One Health approach, which recognizes the interconnection between people, animals, plants, and their shared environment; and transparency, coordination, and collaboration with stakeholders and partners is key to containment of emerging zoonotic diseases.
The Administrator of the United States Agency for International Development and the Director of the Centers for Disease Control and Prevention shall design and implement a program, in collaboration, to the extent possible, with the People’s Republic of China, to reduce the risk of the transmission of dangerous pathogens from animals to people, including strains of coronavirus, Ebola, and influenza, and to foster transparency in reporting the emergence of such zoonotic diseases.
The program should focus on— the investments that reduce most effectively the risk of the transmission of viruses that pose the greatest threat to Americans and United States national security; and building networks and strengthening capacity in labs, institutions of higher education, and other institutions to identify and publicly report on emerging zoonotic diseases.